Proton Therapy and Gliomas: A Systematic Review

• Main Authors: Isabelle Chambrelant, Jordan Eber, Delphine Antoni, Hélène Burckel, Georges Noël, Romane Auvergne
• Format: Article
• Language: English
• Published: MDPI AG 2021-09-01
• Series: Radiation
• Subjects: proton therapy; gliomas; brain tumors; outcomes; systematic review
• Online Access: https://www.mdpi.com/2673-592X/1/3/19

Background: Gliomas are primary cerebral tumors. Radiation therapy plays a key role in their treatment but with a risk of toxicity associated with the dose to and volume of normal tissue that is irradiated. With its precision properties allowing for the increased sparing of healthy tissue, proton therapy could be an interesting option for this pathology. Methods: Two reviewers performed a systematic review of original papers published between 2010 and July 2021 following PRISMA guidelines. We analyzed disease outcomes, toxicity outcomes, or dosimetry data in four separate groups: children/adults and individuals with low-/high-grade gliomas. Results: Among 15 studies, 11 concerned clinical and toxicity outcomes, and 4 reported dosimetry data. Proton therapy showed similar disease outcomes with greater tolerance than conventional radiation therapy, partly due to the better dosimetry plans. Conclusions: This review suggests that proton therapy is a promising technique for glioma treatment. However, studies with a high level of evidence are still needed to validate this finding.